Peripheral blood used in place of bone marrow aspirate for detection of translocation t(11;14) status during minimal residual disease monitoring is cost-effectiveness
A. Lleshi, A. Rainone Department of Medical Oncology, National Cancer Institute, Aviano (PN) Italy. rainoneaniello@gmail.com
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
A. Lleshi, A. Rainone
Peripheral blood used in place of bone marrow aspirate for detection of translocation t(11;14) status during minimal residual disease monitoring is cost-effectiveness
Eur Rev Med Pharmacol Sci
Year: 2016
Vol. 20 - N. 6
Pages: 999-1000